KATIE RIEHL: Open Payments
NPI 1699483404 · ROCKWELL CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 31 payments from 12 companies in 2025. Trend: 2023 $217 · 2024 $346 · 2025 $790
Food & beverage: $567Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $241 |
| E.R. Squibb & Sons, L.L.C. | 8 | $163 |
| Alkermes, Inc. | 5 | $96 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
Products named: COBENFY, ARISTADA, FANAPT, INVEGA SUSTENNA, INGREZZA, REXULTI, VRAYLAR, Auvelity.
Industry payments across IA — which companies pay providers there.
